Reuters logo
BRIEF-Briacell CEO's equity investment advances company's lead cancer product and pipeline expansion
2017年2月27日 / 下午1点42分 / 8 个月前

BRIEF-Briacell CEO's equity investment advances company's lead cancer product and pipeline expansion

Feb 27 (Reuters) - Briacell Therapeutics Corp

* Briacell CEO equity investment advances company’s lead cancer product and pipeline expansion

* BriaCell Therapeutics- President,CEO, William Williams entered non-brokered private placement of 5.4 million units of company at a price of C$0.24/unit

* BriaCell Therapeutics Corp- intends to use proceeds from offering to advance company’s ongoing phase I/IIA clinical trial of Briavax Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below